Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Scott Kinlay, Ph.D., M.B.,B.S.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kinlay S, Young MM, Sherrod R, Gagnon DR. Long-Term Outcomes and Duration of Dual Antiplatelet Therapy After Coronary Intervention With Second-Generation Drug-Eluting Stents: The Veterans Affairs Extended DAPT Study. J Am Heart Assoc. 2023 01 17; 12(2):e027055. PMID: 36645075; PMCID: PMC9939065.
    Citations: 1     Fields:    Translation:Humans
  2. Yuyun MF, Kinlay S, Singh JP, Joseph J. Are arrhythmias the drivers of sudden cardiac death in heart failure with preserved ejection fraction? A review. ESC Heart Fail. 2022 Dec 09. PMID: 36495033.
    Citations:    Fields:    
  3. Kinlay S. Post-PCI Antithrombotic Treatment With High Bleeding Risk. J Am Coll Cardiol. 2022 09 27; 80(13):1238-1240. PMID: 36137673; PMCID: PMC9518787.
    Citations: 1     Fields:    Translation:Humans
  4. Goodney P, Shah S, Hu YD, Suckow B, Kinlay S, Armstrong DG, Geraghty P, Patterson M, Menard M, Patel MR, Conte MS. A systematic review of patient-reported outcome measures patients with chronic limb-threatening ischemia. J Vasc Surg. 2022 05; 75(5):1762-1775. PMID: 35085747; PMCID: PMC9524582.
    Citations:    Fields:    Translation:Humans
  5. Kinlay S, Quach L, Cormack J, Morgenstern N, Hou Y, Young M, Sherrod R, Cho K, Faxon DP, Ramadan R, Gaziano M, Gagnon D. Premature Discontinuation of Dual Antiplatelet Therapy After Coronary Stenting in Veterans: Characteristics and Long-Term Outcomes. J Am Heart Assoc. 2021 05 04; 10(9):e018481. PMID: 33899501; PMCID: PMC8200740.
    Citations: 3     Fields:    Translation:Humans
  6. Latif F, Uyeda L, Edson R, Bhatt DL, Goldman S, Holmes DR, Rao SV, Shunk K, Aggarwal K, Uretsky B, Bolad I, Ziada K, McFalls E, Irimpen A, Truong HT, Kinlay S, Papademetriou V, Velagaleti RS, Rangan BV, Mavromatis K, Shih MC, Banerjee S, Brilakis ES. Response by Latif et al to Letter Regarding Article, "Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial". Circ Cardiovasc Interv. 2020 04; 13(4):e009174. PMID: 32279564.
    Citations:    Fields:    
  7. Latif F, Uyeda L, Edson R, Bhatt DL, Goldman S, Holmes DR, Rao SV, Shunk K, Aggarwal K, Uretsky B, Bolad I, Ziada K, McFalls E, Irimpen A, Truong HT, Kinlay S, Papademetriou V, Velagaleti RS, Rangan BV, Mavromatis K, Shih MC, Banerjee S, Brilakis ES. Stent-Only Versus Adjunctive Balloon Angioplasty Approach for Saphenous Vein Graft Percutaneous Coronary Intervention: Insights From DIVA Trial. Circ Cardiovasc Interv. 2020 02; 13(2):e008494. PMID: 32019343.
    Citations: 2     Fields:    Translation:Humans
  8. Aday AW, Kinlay S, Gerhard-Herman MD. Reply to: 'Post-exercise criteria to diagnose lower extremity peripheral artery disease: Which one should I use in my practice?' by Stivalet et al. Vasc Med. 2019 02; 24(1):78. PMID: 30747602; PMCID: PMC6486175.
    Citations:    Fields:    Translation:Humans
  9. Kinlay S, Bundy M, Chin M, Tobin D, Quinn M, Do JM, Johnson S, Temiyasathit S, Ly S. Reproducibility and validity of a novel invasive method of assessing peripheral microvascular vasomotor function. PLoS One. 2019; 14(1):e0211152. PMID: 30682202; PMCID: PMC6347364.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  10. Banerjee S, Jeon-Slaughter H, Armstrong EJ, Bajzer C, Abu-Fadel M, Khalili H, Prasad A, Bou Dargham B, Kamath P, Addo T, Luna M, Gigliotti O, Foteh M, Cawich I, Kinlay S, Ali M, Ramanan B, Niazi K, Tsai S, Shammas NW, Brilakis ES. Clinical Outcomes and Cost Comparisons of Stent and Non-Stent Interventions in Infrainguinal Peripheral Artery Disease: Insights From the Excellence in Peripheral Artery Disease (XLPAD) Registry. J Invasive Cardiol. 2019 01; 31(1):1-9. PMID: 30611122; PMCID: PMC6428413.
    Citations: 2     Fields:    Translation:Humans
  11. Aday AW, Kinlay S, Gerhard-Herman MD. Comparison of different exercise ankle pressure indices in the diagnosis of peripheral artery disease. Vasc Med. 2018 12; 23(6):541-548. PMID: 29992854.
    Citations: 8     Fields:    Translation:Humans
  12. Ramadan R, Boden WE, Kinlay S. Management of Left Main Coronary Artery Disease. J Am Heart Assoc. 2018 03 31; 7(7). PMID: 29605817; PMCID: PMC5907594.
    Citations: 17     Fields:    Translation:Humans
  13. Mowakeaa S, Dwivedi A, Grossman JR, Parikh G, Curillova Z, Aragam KG, Elmariah S, Kinlay S, Aragam J. Prognosis of patients with secondary mitral regurgitation and reduced ejection fraction. Open Heart. 2018; 5(1):e000745. PMID: 29344383.
    Citations: 5     Fields:    
  14. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FGR, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RAG, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME, Halperin JL, Levine GN, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, Cigarroa JE, Curtis LH, Fleisher LA, Gentile F, Gidding S, Hlatky MA, Ikonomidis J, Joglar J, Pressler SJ, Wijeysundera DN. 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary. Vasc Med. 2017 06; 22(3):NP1-NP43. PMID: 28494710.
    Citations: 37     Fields:    Translation:Humans
  15. Sawlani NN, Kinlay S. Claudication: Pay for Structured Exercise or Go Take a Hike. JACC Cardiovasc Interv. 2017 04 10; 10(7):725-727. PMID: 28385411.
    Citations: 1     Fields:    Translation:Humans
  16. Armstrong EJ, Gornik HL, Hamburg NM, Kinlay S. The 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: An interview with SVM members of the writing committee. Vasc Med. 2017 04; 22(2):170-173. PMID: 28429665.
    Citations:    Fields:    Translation:Humans
  17. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FGR, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RAG, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017 03 21; 69(11):e71-e126. PMID: 27851992.
    Citations: 139     Fields:    Translation:Humans
  18. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FGR, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RAG, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017 03 21; 69(11):1465-1508. PMID: 27851991.
    Citations: 128     Fields:    Translation:Humans
  19. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017 03 21; 135(12):e686-e725. PMID: 27840332; PMCID: PMC5479414.
    Citations: 153     Fields:    Translation:Humans
  20. Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FG, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RA, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017 03 21; 135(12):e726-e779. PMID: 27840333; PMCID: PMC5477786.
    Citations: 187     Fields:    Translation:Humans
  21. Wimmer NJ, Dufour AB, Cho K, Gagnon DR, Quach L, Ly S, Do JM, Ostrowski S, Michael Gaziano J, Faxon DP, Kinlay S. Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting. Catheter Cardiovasc Interv. 2017 Jun 01; 89(7):1176-1184. PMID: 27860195.
    Citations: 1     Fields:    Translation:Humans
  22. Kinlay S, Michel T, Leopold JA. The Future of Vascular Biology and Medicine. Circulation. 2016 Jun 21; 133(25):2603-9. PMID: 27324355; PMCID: PMC5475273.
    Citations: 11     Fields:    Translation:HumansAnimals
  23. Kinlay S. Management of Critical Limb Ischemia. Circ Cardiovasc Interv. 2016 Feb; 9(2):e001946. PMID: 26858079.
    Citations: 27     Fields:    Translation:Humans
  24. Berry NC, Manyoo A, Oldham WM, Stephens TE, Goldstein RH, Waxman AB, Tracy JA, Leary PJ, Leopold JA, Kinlay S, Opotowsky AR, Systrom DM, Maron BA. Protocol for exercise hemodynamic assessment: performing an invasive cardiopulmonary exercise test in clinical practice. Pulm Circ. 2015 Dec; 5(4):610-8. PMID: 26697168; PMCID: PMC4671735.
    Citations: 22     
  25. Thukkani AK, Agrawal K, Prince L, Smoot KJ, Dufour AB, Cho K, Gagnon DR, Sokolovskaya G, Ly S, Temiyasathit S, Faxon DP, Gaziano JM, Kinlay S. Long-Term Outcomes in Patients With Diabetes Mellitus Related to Prolonging Clopidogrel More Than 12 Months After Coronary Stenting. J Am Coll Cardiol. 2015 Sep 08; 66(10):1091-101. PMID: 26337986; PMCID: PMC4578293.
    Citations: 10     Fields:    Translation:Humans
  26. Kinlay S. Does this study make my aorta look fat? Circulation. 2015 Oct 27; 132(17):1600-1. PMID: 26338954; PMCID: PMC4624497.
    Citations: 2     Fields:    Translation:Humans
  27. Siddiqi OK, Smoot KJ, Dufour AB, Cho K, Young M, Gagnon DR, Ly S, Temiyasathit S, Faxon DP, Gaziano JM, Kinlay S. Outcomes with prolonged clopidogrel therapy after coronary stenting in patients with chronic kidney disease. Heart. 2015 Oct; 101(19):1569-76. PMID: 26209334; PMCID: PMC4580134.
    Citations: 10     Fields:    Translation:Humans
  28. Thukkani AK, Kinlay S. Endovascular intervention for peripheral artery disease. Circ Res. 2015 Apr 24; 116(9):1599-613. PMID: 25908731; PMCID: PMC4504240.
    Citations: 41     Fields:    Translation:Humans
  29. Gray BH, Jaff MR, Slovut DP, Bacharach JM, Carman T, Creager M, Halperin J, von Mering G, Kinlay S. The first 10 years of the American Board of Vascular Medicine. Vasc Med. 2015 Feb; 20(1):69-73. PMID: 25520319.
    Citations:    Fields:    Translation:Humans
  30. Kinlay S. Coronary artery spasm as a cause of angina. Circulation. 2014 Apr 29; 129(17):1717-9. PMID: 24573350; PMCID: PMC4507517.
    Citations: 6     Fields:    Translation:Humans
  31. Nohria A, Kinlay S, Buck JS, Redline W, Copeland-Halperin R, Kim S, Beckman JA. The effect of salsalate therapy on endothelial function in a broad range of subjects. J Am Heart Assoc. 2014 Jan 03; 3(1):e000609. PMID: 24390146.
    Citations: 15     Fields:    Translation:Humans
  32. Kinlay S. Prospects for multimodality imaging in peripheral artery disease. Circ Cardiovasc Imaging. 2014 Jan; 7(1):3-4. PMID: 24449544.
    Citations:    Fields:    Translation:Animals
  33. McCabe JM, Armstrong EJ, Ku I, Kulkarni A, Hoffmayer KS, Bhave PD, Waldo SW, Hsue P, Stein JC, Marcus GM, Kinlay S, Ganz P. Physician accuracy in interpreting potential ST-segment elevation myocardial infarction electrocardiograms. J Am Heart Assoc. 2013 Oct 04; 2(5):e000268. PMID: 24096575.
    Citations: 9     Fields:    Translation:Humans
  34. Turner TE, Waldo SW, Kulkarni A, Armstrong EJ, Hoffmayer KS, Kinlay S, Hsue P, Ganz P, McCabe JM. Long-term outcomes of patients sent emergently to the catheterization laboratory for possible primary percutaneous coronary intervention. Am J Cardiol. 2013 Dec 01; 112(11):1745-9. PMID: 24063836.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  35. Kinlay S. Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery disease. Circulation. 2013 Mar 19; 127(11):1241-50. PMID: 23509032; PMCID: PMC4507406.
    Citations: 13     Fields:    Translation:Humans
  36. Waldo SW, Armstrong EJ, Kulkarni A, Hoffmayer K, Kinlay S, Hsue P, Ganz P, McCabe JM. Comparison of clinical characteristics and outcomes of cardiac arrest survivors having versus not having coronary angiography. Am J Cardiol. 2013 May 01; 111(9):1253-8. PMID: 23391104.
    Citations: 7     Fields:    Translation:Humans
  37. Zamani P, Schwartz GG, Olsson AG, Rifai N, Bao W, Libby P, Ganz P, Kinlay S. Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study. J Am Heart Assoc. 2013 Jan 28; 2(1):e003103. PMID: 23525424.
    Citations: 32     Fields:    Translation:Humans
  38. Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC, Crowley K, Goto S, Ohman EM, Bakris GL, Perlstein TS, Kinlay S, Bhatt DL. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. Eur Heart J. 2013 Apr; 34(16):1204-14. PMID: 23144048.
    Citations: 73     Fields:    Translation:Humans
  39. McCabe JM, Armstrong EJ, Hoffmayer KS, Bhave PD, MacGregor JS, Hsue P, Stein JC, Kinlay S, Ganz P. Impact of door-to-activation time on door-to-balloon time in primary percutaneous coronary intervention for ST-segment elevation myocardial infarctions: a report from the Activate-SF registry. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):672-9. PMID: 22949494.
    Citations: 8     Fields:    Translation:Humans
  40. Armstrong EJ, Kulkarni AR, Bhave PD, Hoffmayer KS, Macgregor JS, Stein JC, Kinlay S, Ganz P, McCabe JM. Electrocardiographic criteria for ST-elevation myocardial infarction in patients with left ventricular hypertrophy. Am J Cardiol. 2012 Oct 01; 110(7):977-83. PMID: 22738872.
    Citations: 7     Fields:    Translation:Humans
  41. McCabe JM, Armstrong EJ, Kulkarni A, Hoffmayer KS, Bhave PD, Garg S, Patel A, MacGregor JS, Hsue P, Stein JC, Kinlay S, Ganz P. Prevalence and factors associated with false-positive ST-segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention–capable centers: a report from the Activate-SF registry. Arch Intern Med. 2012 Jun 11; 172(11):864-71. PMID: 22566489.
    Citations: 28     Fields:    Translation:Humans
  42. Faxon DP, Lawler E, Young M, Gaziano M, Kinlay S. Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study. Circ Cardiovasc Interv. 2012 Jun; 5(3):372-80. PMID: 22668555.
    Citations: 10     Fields:    Translation:Humans
  43. Bashore TM, Balter S, Barac A, Byrne JG, Cavendish JJ, Chambers CE, Hermiller JB, Kinlay S, Landzberg JS, Laskey WK, McKay CR, Miller JM, Moliterno DJ, Moore JW, Oliver-McNeil SM, Popma JJ, Tommaso CL. 2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: A report of the American College of Cardiology Foundation Task Force on Expert Consensus documents developed in collaboration with the Society of Thoracic Surgeons and Society for Vascular Medicine. J Am Coll Cardiol. 2012 Jun 12; 59(24):2221-305. PMID: 22575325.
    Citations: 42     Fields:    Translation:Humans
  44. Bashore TM, Balter S, Barac A, Byrne JG, Cavendish JJ, Chambers CE, Hermiller JB, Kinlay S, Landzberg JS, Laskey WK, McKay CR, Miller JM, Moliterno DJ, Moore JW, Oliver-McNeil SM, Popma JJ. 2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: American College of Cardiology Foundation Task Force on expert consensus documents Society of Thoracic Surgeons Society for Vascular Medicine. Catheter Cardiovasc Interv. 2012 Sep 01; 80(3):E37-49. PMID: 22570114.
    Citations: 1     Fields:    Translation:Humans
  45. Armstrong EJ, Kulkarni AR, Hoffmayer KS, Bhave PD, MacGregor JS, Hsue P, Stein JC, Kinlay S, Ganz P, McCabe JM. Delaying primary percutaneous coronary intervention for computed tomographic scans in the emergency department. Am J Cardiol. 2012 Aug 01; 110(3):345-9. PMID: 22534052.
    Citations: 1     Fields:    Translation:Humans
  46. Todoran TM, Connors G, Engelson BA, Sobieszczyk PS, Eisenhauer AC, Kinlay S. Femoral artery percutaneous revascularization for patients with critical limb ischemia: outcomes compared to patients with claudication over 2.5 years. Vasc Med. 2012 Jun; 17(3):138-44. PMID: 22496125.
    Citations: 4     Fields:    Translation:Humans
  47. Hoffmeister P, Gautam S, Peralta A, Kinlay S. Intravascular ultrasound-assisted coronary sinus lead implant in patient with contrast anaphylaxis. Pacing Clin Electrophysiol. 2013 Mar; 36(3):e74-6. PMID: 22469186.
    Citations: 1     Fields:    Translation:Humans
  48. Zamani P, Ganz P, Libby P, Sutradhar SC, Rifai N, Nicholls SJ, Nissen SE, Kinlay S. Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study. Am Heart J. 2012 Apr; 163(4):735-40. PMID: 22520542.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  49. Maron BA, Bhatt DL, Nykiel M, Kinlay S, Waxman AB. Protocol for vasoreactivity testing with epoprostenol in pulmonary hypertension. Crit Pathw Cardiol. 2012 Mar; 11(1):40-2. PMID: 22337220.
    Citations: 3     Fields:    Translation:Humans
  50. Kinlay S. Role of C-reactive protein when prescribing a statin. Curr Atheroscler Rep. 2012 Feb; 14(1):26-32. PMID: 22125118.
    Citations:    Fields:    Translation:HumansPHPublic Health
  51. Kinlay S. The trials and tribulations of percutaneous coronary intervention in hospitals without on-site CABG surgery. JAMA. 2011 Dec 14; 306(22):2507-9. PMID: 22166613; PMCID: PMC4504239.
    Citations:    Fields:    Translation:Humans
  52. Moukarbel GV, Kitkungvan D, Safiia MA, Aragam J, Kinlay S. Asymptomatic embolized HELEX PFO closure device: catheter based retrieval and value of routine echocardiography the following day. Int J Cardiol. 2012 Jul 26; 158(3):e57-9. PMID: 22104997.
    Citations:    Fields:    Translation:Humans
  53. Bhave PD, Hoffmayer KS, Armstrong EJ, Garg S, Patel A, Macgregor JS, Stein JC, Kinlay S, Ganz P, McCabe JM. Predictors of depressed left ventricular function in patients presenting with ST-elevation myocardial infarction. Am J Cardiol. 2012 Feb 01; 109(3):327-31. PMID: 22078964.
    Citations:    Fields:    Translation:Humans
  54. Kinlay S. Changes in stroke epidemiology, prevention, and treatment. Circulation. 2011 Nov 08; 124(19):e494-6. PMID: 22064961; PMCID: PMC4501778.
    Citations: 20     Fields:    Translation:Humans
  55. Kinlay S. Grasping the nettle and femoral artery stenting. Circ Cardiovasc Interv. 2011 Oct 01; 4(5):407-9. PMID: 22010187.
    Citations: 1     Fields:    Translation:Humans
  56. Todoran TM, Sobieszczyk PS, Levy MS, Perry TE, Shook DC, Kinlay S, Davidson MJ, Eisenhauer AC. Percutaneous extraction of right atrial mass using the Angiovac aspiration system. J Vasc Interv Radiol. 2011 Sep; 22(9):1345-7. PMID: 21856509.
    Citations: 12     Fields:    Translation:HumansCells
  57. Kinlay S. Fire in the hole: carotid stenting versus endarterectomy. Circulation. 2011 Jun 07; 123(22):2522-5. PMID: 21606395.
    Citations: 4     Fields:    Translation:Humans
  58. Connors G, Todoran TM, Engelson BA, Sobieszczyk PS, Eisenhauer AC, Kinlay S. Percutaneous revascularization of long femoral artery lesions for claudication: patency over 2.5 years and impact of systematic surveillance. Catheter Cardiovasc Interv. 2011 Jun 01; 77(7):1055-62. PMID: 20853355.
    Citations: 5     Fields:    Translation:Humans
  59. Zamani P, Kinlay S. Long-term risk of clinical events from stenting side branches of coronary bifurcation lesions with drug-eluting and bare-metal stents: an observational meta-analysis. Catheter Cardiovasc Interv. 2011 Feb 01; 77(2):202-12. PMID: 20824754.
    Citations: 3     Fields:    Translation:Humans
  60. Levy MS, Todoran TM, Kinlay S, Sobieszczyk PS, Shook D, Gross WL, Eisenhauer AC. Use of real-time 3D transesophageal echocardiography in percutaneous intervention of a flush-occluded pulmonary vein. Circ Cardiovasc Interv. 2010 Aug; 3(4):394-5. PMID: 20716759.
    Citations:    Fields:    Translation:Humans
  61. Zamani P, Kaufman J, Kinlay S. Ischemic steal syndrome following arm arteriovenous fistula for hemodialysis. Vasc Med. 2009 Nov; 14(4):371-6. PMID: 19808723.
    Citations: 10     Fields:    Translation:Humans
  62. Larose E, Behrendt D, Kinlay S, Selwyn AP, Ganz P, Fang JC. Endothelin-1 is a key mediator of coronary vasoconstriction in patients with transplant coronary arteriosclerosis. Circ Heart Fail. 2009 Sep; 2(5):409-16. PMID: 19808370.
    Citations: 3     Fields:    Translation:Humans
  63. Fraley AE, Schwartz GG, Olsson AG, Kinlay S, Szarek M, Rifai N, Libby P, Ganz P, Witztum JL, Tsimikas S. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial. J Am Coll Cardiol. 2009 Jun 09; 53(23):2186-96. PMID: 19497447.
    Citations: 37     Fields:    Translation:HumansCells
  64. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Bao W, Libby P, Ganz P. Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study. Atherosclerosis. 2009 Oct; 206(2):551-5. PMID: 19394618.
    Citations: 4     Fields:    Translation:Humans
  65. Tsyvine D, Hartzell M, Bonaca MP, Connors G, Kinlay S. Subclavian stenosis causing angina after coronary artery bypass grafting. Med J Aust. 2009 Mar 16; 190(6):331-2. PMID: 19296816.
    Citations:    Fields:    Translation:Humans
  66. Kinlay S. Quality of life with PCI versus medical therapy in stable coronary disease. N Engl J Med. 2008 Nov 20; 359(21):2291; author reply 2292. PMID: 19031544.
    Citations:    Fields:    Translation:Humans
  67. Kinlay, S. Quality of Life with PCI versus Medical Therapy in Stable Coronary Disease. New England J Med. 2008; 359(21):2291.
  68. Kinlay S. Vascular form and function: two mechanisms for cardiovascular prevention. Eur Heart J. 2008 Jul; 29(14):1711-3. PMID: 18539586.
    Citations:    Fields:    Translation:Humans
  69. Zamani P, Kinlay S. Long-term Outcomes Following Percutaneous Interventions of Coronary Artery Bifurcation Lesions Depend on Procedural and Traditional Atherosclerosis Risk Factors. 2008.
  70. Kinlay S. Is C-reactive protein reduction wth cholesterol-lowering therapies a lipid-independent effect?. Cardiology Review. 2008; 25(2):45.
  71. Kinlay S. Cholesterol-lowering therapies and C-reactive protein. Cardiology Review. 2008; 25(2):41-44.
  72. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Szarek M, Waters DD, Libby P, Ganz P. Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study. Arterioscler Thromb Vasc Biol. 2008 Jan; 28(1):142-7. PMID: 17991875.
    Citations: 26     Fields:    Translation:Humans
  73. Larose E, Behrendt D, Kinlay S, Selwyn AP, Ganz P, Fang J. Markedly enhanced activity of endothelin-1 in transplant coronary arteriosclerosis. 2007.
  74. Kinlay, S. Vascular biology. Vascular Medicine and Endovascular Interventions. Rooke TW, Sullivan TM, Jaff MR, eds. 2007.
  75. Kinlay S. Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis. J Am Coll Cardiol. 2007 May 22; 49(20):2003-9. PMID: 17512355.
    Citations: 45     Fields:    Translation:Humans
  76. Larose E, Kinlay S, Selwyn AP, Yeghiazarians Y, Yucel EK, Kacher DF, Libby P, Ganz P. Improved characterization of atherosclerotic plaques by gadolinium contrast during intravascular magnetic resonance imaging of human arteries. Atherosclerosis. 2008 Feb; 196(2):919-25. PMID: 17391676.
    Citations: 12     Fields:    Translation:Humans
  77. Stone PH, Coskun AU, Kinlay S, Popma JJ, Sonka M, Wahle A, Yeghiazarians Y, Maynard C, Kuntz RE, Feldman CL. Regions of low endothelial shear stress are the sites where coronary plaque progresses and vascular remodelling occurs in humans: an in vivo serial study. Eur Heart J. 2007 Mar; 28(6):705-10. PMID: 17347172.
    Citations: 40     Fields:    Translation:Humans
  78. Kinlay S, Ganz P. Endothelial vasodilatory dysfunction: basic concepts and practical implementation. Endothelial Dysfunctions and Vascular Disease. De Caterina R, Libby P, eds. 2007; 179-188.
  79. Mauri L, Kinlay S. Adjunctive devices: Atherectomy, thrombectomy, embolic protection, IVUS, Doppler, and pressure wires. Interventional Cardiology. King SB III, Yeung AC, eds. 2007; 93-108.
  80. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Szarek M, Libby P, Ganz P. Risk of death and beneficial effects of statins in acute coronary syndromes related to inflammatory markers in the MIRACL study. 2006.
  81. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Szarek M, Waters D, Libby P, Ganz P. Risk of stroke after acute coronary syndromes in the MIRACL study related to baseline inflammatory markers. 2006.
  82. Kinlay S, Egido J. Inflammatory biomarkers in stable atherosclerosis. Am J Cardiol. 2006 Dec 04; 98(11A):2P-8P. PMID: 17126676.
    Citations: 17     Fields:    Translation:Humans
  83. Crittenden MD, Zamani P, Kelley L, Kinlay S. TIMI frame counts and graft patency: Feasibility of a quantitative method for assessing flow characteristics in aortocoronary bypass grafts. 2006.
  84. Behrendt D, Beltrame J, Hikiti H, Wainstein M, Kinlay S, Selwyn AP, Ganz P, Fang JC. Impact of coronary endothelial function on the progression of cardiac transplant-associated arteriosclerosis: effect of anti-oxidant vitamins C and E. J Heart Lung Transplant. 2006 Apr; 25(4):426-33. PMID: 16563973.
    Citations: 4     Fields:    Translation:Humans
  85. Feldman CL, Coskun AU, Yeghiazarians Y, Kinlay S, Wahle A, Olszewski ME, Rossen JD, Sonka M, Popma JJ, Orav J, Kuntz RE, Stone PH. Remodeling characteristics of minimally diseased coronary arteries are consistent along the length of the artery. Am J Cardiol 2006; 97: 13-6. 2006; 97(1):13-6.
  86. Kinlay S. Potential vascular benefits of statins. Am J Med. 2005 Dec; 118 Suppl 12A:62-7. PMID: 16356810.
    Citations: 6     Fields:    Translation:Humans
  87. Feldman CL, Coskun AU, Yeghiazarians Y, Kinlay S, Wahle A, Olszewski ME, Rossen JD, Sonka M, Popma JJ, Orav J, Kuntz RE, Stone PH. Remodeling characteristics of minimally diseased coronary arteries are consistent along the length of the artery. Am J Cardiol. 2006 Jan 01; 97(1):13-6. PMID: 16377275.
    Citations: 9     Fields:    Translation:Humans
  88. Larose E, Yeghiazarians Y, Libby P, Yucel EK, Aikawa M, Kacher DF, Aikawa E, Kinlay S, Schoen FJ, Selwyn AP, Ganz P. Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging. Circulation. 2005 Oct 11; 112(15):2324-31. PMID: 16203910.
    Citations: 37     Fields:    Translation:Humans
  89. Kinlay S. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people? Med J Aust. 2005 Jun 06; 182(11):597-8; author reply 598. PMID: 15938695.
    Citations:    Fields:    Translation:Humans
  90. Stone PH, Lloyd-Jones DM, Kinlay S, Frei B, Carlson W, Rubenstein J, Andrews TC, Johnstone M, Sopko G, Cole H, Orav J, Selwyn AP, Creager MA. Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study. Circulation. 2005 Apr 12; 111(14):1747-55. PMID: 15809368.
    Citations: 16     Fields:    Translation:HumansCTClinical Trials
  91. Kinlay S. Pleiotropic effects of statins: What do we need to learn and how can we get there?. Lipid Letter. 2005; 4(4):2-11.
  92. Kinlay S. What do we know about pleiotropic effects?. Lipid Letter. 2005; 4:1-7.
  93. Kinlay S, Moulton K. Atherosclerosis: A lipid disorder and a chronic inflammatory disease. Clinical, Interventional, and Investigational Thrombocardiology. Becker RC, Harrington RA, eds. 2005.
  94. Larose E, Yeghiazarians Y, Yucel EK, Kacher D, Aikawa M, Rabkin-Aikawa E, Libby P, Kinlay S, Selwyn A, Ganz P. Intravascular magnetic resonance imaging to characterize the composition of human atherosclerotic plaques in vivo. 2004.
  95. Larose E, Behrendt D, Kinlay S, Selwyn A, Ganz P, Fang J. Endogenous endothelin-1: a potent coronary vasoconstrictor in cardiac transplant recipients with arteriosclerosis. 2004.
  96. Shaw J, Kinlay S, MacNeill B, Eisenhauer AC. Biomechanical properties differ between the coronary and non-coronary vascular beds. A role in the vulnerable plaque?. 2004.
  97. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Sasiela WJ, Szarek M, Ganz P, Libby P. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation. 2004 Jul 27; 110(4):386-91. PMID: 15262833.
    Citations: 28     Fields:    Translation:HumansCTClinical Trials
  98. Stone PH, Lloyd-Jones DM, Johnstone M, Carlson W, Rubenstein J, Creager M, Frei B, Sopko G, Clark ME, Maccallum G, Kinlay S, Orav J, Selwyn AP. Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics. Am Heart J. 2004 May; 147(5):875-82. PMID: 15131545.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  99. Kinlay S, Behrendt D, Fang JC, Delagrange D, Morrow J, Witztum JL, Rifai N, Selwyn AP, Creager MA, Ganz P. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol. 2004 Feb 18; 43(4):629-34. PMID: 14975474.
    Citations: 22     Fields:    Translation:HumansCTClinical Trials
  100. Kinlay S, Libby P, Ganz P. For the MIRACL Study Investigators. Early Intervention with Atorvastatin Modulates Th1/Th2 Imbalance in Patients with Acute Coronary Syndrome: From Bedside to Bench. Response. Circulation. 2004; 109:e213-e214.
  101. Horton DB, LaClair SJ, Varo N, Merchant BC, Kinlay S, Ganz P, Schonbeck U. HMG-CoA reductase inhibitors diminish interstitial collagen turnover in human vascular smooth muscle cells. 2003.
  102. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Sasiela WJ, Szarek M, Libby P, Ganz P, for the MIRACL Investigators. Soluble CD40L, risk of recurrent cardiac events and atorvastatin in the MIRACL Study. 2003.
  103. Kinlay S, Ganz P. Early statin therapy in acute coronary syndromes. Semin Vasc Med. 2003 Nov; 3(4):419-24. PMID: 15199449.
    Citations:    Fields:    Translation:HumansPHPublic Health
  104. Stone PH, Coskun AU, Yeghiazarians Y, Kinlay S, Popma JJ, Kuntz RE, Feldman CL. Prediction of sites of coronary atherosclerosis progression: In vivo profiling of endothelial shear stress, lumen, and outer vessel wall characteristics to predict vascular behavior. Curr Opin Cardiol. 2003 Nov; 18(6):458-70. PMID: 14597887.
    Citations: 28     Fields:    Translation:Humans
  105. Kinlay S. Early statin therapy in acute coronary syndromes. Minerva Cardioangiol. 2003 Oct; 51(5):577-84. PMID: 14551525.
    Citations:    Fields:    Translation:Humans
  106. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz P. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation. 2003 Sep 30; 108(13):1560-6. PMID: 12975259.
    Citations: 77     Fields:    Translation:HumansCTClinical Trials
  107. Coskun AU, Yeghiazarians Y, Kinlay S, Clark ME, Ilegbusi OJ, Wahle A, Sonka M, Popma JJ, Kuntz RE, Feldman CL, Stone PH. Reproducibility of coronary lumen, plaque, and vessel wall reconstruction and of endothelial shear stress measurements in vivo in humans. Catheter Cardiovasc Interv. 2003 Sep; 60(1):67-78. PMID: 12929106.
    Citations: 14     Fields:    Translation:Humans
  108. Stone PH, Coskun AU, Kinlay S, Clark ME, Sonka M, Wahle A, Ilegbusi OJ, Yeghiazarians Y, Popma JJ, Orav J, Kuntz RE, Feldman CL. Effect of endothelial shear stress on the progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans: in vivo 6-month follow-up study. Circulation. 2003 Jul 29; 108(4):438-44. PMID: 12860915.
    Citations: 111     Fields:    Translation:HumansCTClinical Trials
  109. Nohria A, Garrett L, Johnson W, Kinlay S, Ganz P, Creager MA. Endothelin-1 and vascular tone in subjects with atherogenic risk factors. Hypertension. 2003 Jul; 42(1):43-8. PMID: 12756218.
    Citations: 10     Fields:    Translation:Humans
  110. Kinlay S, Selwyn AP. Effects of statins on inflammation in patients with acute and chronic coronary syndromes. Am J Cardiol. 2003 Feb 20; 91(4A):9B-13B. PMID: 12615293.
    Citations: 7     Fields:    Translation:Humans
  111. Page J, Heller RF, Kinlay S, Lim LL, Qian W, Suping Z, Kongpatanakul S, Akhtar M, Khedr S, Macharia W. Attitudes of developing world physicians to where medical research is performed and reported. BMC Public Health. 2003 Jan 16; 3:6. PMID: 12529182.
    Citations: 26     Fields:    Translation:Humans
  112. Kinlay S. When should statin therapy begin following an acute coronary syndrome?. Harrison’s Advances in Cardiology. Braunwald E, ed. 2003.
  113. Schönbeck U, Gerdes N, Varo N, Reynolds RS, Horton DB, Bavendiek U, Robbie L, Ganz P, Kinlay S, Libby P. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. Circulation. 2002 Dec 03; 106(23):2888-93. PMID: 12460867.
    Citations: 24     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
  114. Fang JC, Kinlay S, Behrendt D, Hikita H, Witztum JL, Selwyn AP, Ganz P. Circulating autoantibodies to oxidized LDL correlate with impaired coronary endothelial function after cardiac transplantation. Arterioscler Thromb Vasc Biol. 2002 Dec 01; 22(12):2044-8. PMID: 12482832.
    Citations: 10     Fields:    Translation:HumansCells
  115. Behrendt D, Liao JK, Kinlay S, Creager MA, Selwyn AP, Ganz P. Expression and activity of endothelial nitric oxide syntahse enzyme (eNOS) in patients with endothelial dysfunction. 2002.
  116. Kinlay S, Grewal J, Manuelin D, Fang JC, Selwyn AP, Bittl JA, Ganz P. Coronary flow velocity and disturbed flow predict adverse clinical outcome after coronary angioplasty. Arterioscler Thromb Vasc Biol. 2002 Aug 01; 22(8):1334-40. PMID: 12171797.
    Citations: 2     Fields:    Translation:Humans
  117. Kinlay S, Timms T, Clark M, Karam C, Bilodeau T, Ridker PM, Rifai N, Carlson W, Lloyd-Jones DM, Johnstone M, Rubenstein J, Alexander S, Orav J, Stone PH. Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia. Am J Cardiol. 2002 May 15; 89(10):1205-7. PMID: 12008177.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  118. Orford JL, Kinlay S, Adams MR, Simon DI, Selwyn AP. Clopidogrel inhibits shear-induced platelet function. Platelets. 2002 May; 13(3):187-9. PMID: 12180502.
    Citations: 1     Fields:    Translation:HumansCells
  119. Fang JC, Kinlay S, Beltrame J, Hikiti H, Wainstein M, Behrendt D, Suh J, Frei B, Mudge GH, Selwyn AP, Ganz P. Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet. 2002 Mar 30; 359(9312):1108-13. PMID: 11943259.
    Citations: 37     Fields:    Translation:HumansCTClinical Trials
  120. Baim D, Brady TJ, Casscells SW, Dunne M, Fayad Z, Fuster V, Gazelle S, Heldman A, Hatsukami T, Kinlay S, Lafont A, Lee R, Libby P, Meier B, Muller JE, Naghavi M, O'Donnell C, Perin E, Rekhter M, Rumberger J, Russell M, Schwartz R, Selwyn A, Strauss HW, Tearney G, Tomaru T, Tuzcu EM, Wasserman B. Thoughts on the role of the healing professions and the events of September 11, 2001. Circulation. 2002 Mar 26; 105(12):1509-10. PMID: 11914263.
    Citations:    Fields:    Translation:Humans
  121. Nohria A, Garrett L, Johnson W, Kinlay S, Ganz P, Creager MA. Activity of endothelin-1 is increased in the forearm resistance vessels of subjects with hypertension. 2002.
  122. Stone PH, Coskun AU, Kinlay S, Clark ME, Sonka M, Wahle A, Ilegbusi OJ, Popma JJ, Kuntz RE, Feldman CL. Prediction of sites of progression of native coronary disease in-vivo based on identification of sites of low endothelial shear stress. 2002.
  123. Kinlay S, Rifai N, Libby P, Ganz P, on behalf of the MIRACL Investigators. Effect of Atorvastatin on C-reactive protein in patients with acute coronary syndromes: A substudy of the MIRACL trial. 2002.
  124. Behrendt D, Liao JK, Kinlay S, Creager MA, Selwyn AP, Ganz P. Endothelial vasomotor function in humans: Relation to the expression of endothelial nitric oxide synthase. 2002.
  125. Feldman CL, Kinlay S, Coskun AU, Clark ME, Sonka M, Wahle A, Ilegbusi OJ, Popma JJ, Kuntz RE, Stone PH. In-vivo prediction of outward remodeling in native portions of stented coronary arteries associated with sites of high endothelial shear stress at the time of deployment. 2002.
  126. Kinlay S, Coskun AU, Feldman CL, Clark ME, Sonka M, Wahle A, Ilegbusi OJ, Popma JJ, Kuntz RE, Stone PH. Endothelial shear stress identified in vivo within the stent is related to in-stent restenosis and remodeling of stented coronary arteries. 2002.
  127. Coskun AU, Kinlay S, Clark ME, Sonka M, Wahle A, Ilegbusi OJ, Popma JJ, Kuntz RE, Feldman CL, Stone PH. Reproducibility of three-dimensional lumen, plaque, and outer vessel reconstructions and of endothelial shear stress measurements in vivo to determine progression of atherosclerosis. 2002.
  128. Kinlay S, Ganz P, Creager MA. Nitric oxide and the regulation of arterial elasticity; Right idea, wrong vascular bed? – Response [Letter]. Hypertension. 2002; 39:e26.
  129. Kinlay S, Coskun AU, Sonka M, Wahle A, Ilegbusi OJ, Popma JJ, Stone PH, Feldman CL. Reproducibility of coronary endothelial shear stress measurements in-vivo to determine progression of atherosclerosis. 2001.
  130. Kinlay S, Creager MA, Fukumoto M, Hikita H, Fang JC, Selwyn AP, Ganz P. Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo. Hypertension. 2001 Nov; 38(5):1049-53. PMID: 11711496.
    Citations: 101     Fields:    Translation:Humans
  131. Kinlay S. Intravascular MRI. 2001.
  132. Beckman JA, Ganz J, Creager MA, Ganz P, Kinlay S. Relationship of clinical presentation and calcification of culprit coronary artery stenoses. Arterioscler Thromb Vasc Biol. 2001 Oct; 21(10):1618-22. PMID: 11597935.
    Citations: 40     Fields:    Translation:Humans
  133. Kinlay S, Kacher D, Yeghiazarians Y, Aikawa M, Selwyn AP, Ganz P, Yucel K. . Intravascular Magnetic Resonance Imaging of Atherosclerotic Plaque. 2001.
  134. Kinlay S, Behrendt D, Wainstein M, Beltrame J, Fang JC, Creager MA, Selwyn AP, Ganz P. Role of endothelin-1 in the active constriction of human atherosclerotic coronary arteries. Circulation. 2001 Sep 04; 104(10):1114-8. PMID: 11535565.
    Citations: 34     Fields:    Translation:Humans
  135. Kinlay S, Libby P, Ganz P. Endothelial function and coronary artery disease. Curr Opin Lipidol. 2001 Aug; 12(4):383-9. PMID: 11507322.
    Citations: 73     Fields:    Translation:HumansAnimals
  136. Kwok OH, Landzberg MJ, Kinlay S, Marcus KC, Rogers C. Percutaneous coronary intervention and subsequent endovascular beta-radiation brachytherapy in a 14-year-old with repaired anomalous left coronary artery from pulmonary artery. J Invasive Cardiol. 2001 Jun; 13(6):494-500. PMID: 11385177.
    Citations: 1     Fields:    Translation:Humans
  137. Grewal J, Ganz P, Selwyn A, Kinlay S. Usefulness of intravascular ultrasound in preventing stenting of hazy areas adjacent to coronary stents and its support of support spot-stenting. Am J Cardiol. 2001 Jun 01; 87(11):1246-9. PMID: 11377348.
    Citations: 4     Fields:    Translation:Humans
  138. Kwok OH, Prpic R, Kinlay S, Giri S, Popma J, Fischell T. Quantitative angiographic outcome after intracoronary pullback atherectomy. Am J Cardiol. 2001 May 01; 87(9):1108-10, A9. PMID: 11348613.
    Citations:    Fields:    Translation:Humans
  139. Kinlay S. What has intravascular ultrasound taught us about plaque biology? Curr Atheroscler Rep. 2001 May; 3(3):260-6. PMID: 11286648.
    Citations:    Fields:    Translation:HumansAnimals
  140. Kinlay JR, O'Connell DL, Kinlay S. Risk factors for mastitis in breastfeeding women: results of a prospective cohort study. Aust N Z J Public Health. 2001 Apr; 25(2):115-20. PMID: 11357905.
    Citations: 17     Fields:    Translation:Humans
  141. Behrendt D, Wainstein M, Ganz P, Kinlay S, Fang J. Vitamin C and E retard the progression of transplant associated coronary arteriosclerosis-impact of baseline endothelial function. 2001.
  142. Wainstain MV, Ganz J, Behrendt D, Fang JC, Morrow J, Ganz P, Selwyn AP, Kinlay S. The effect of long-term vitamin E and C therapy on coronary microvascular endothelial function in patients with coronary disease: A prospective randomized trial. 2001.
  143. Timms TA, Kinlay S, Ridker P, Clark M, Karam MC, Johnstone MT, Carlson WD, Ramirez A, Lloyd-Jones D, Alexander S, Rubenstein J, Stone PH. Low density lipoprotein reduction is associated with C-reactive protein decline in patients with stable coronary disease. 2001.
  144. Adams MR, Blake GJ, Kinlay S, Rogers C. Rheolytic thrombectomy for in-stent thrombosis: creating a diagnostic window. J Interv Cardiol. 2001 Feb; 14(1):27-31. PMID: 12053323.
    Citations:    Fields:    Translation:Humans
  145. Orford JL, Kinlay S, Fernandes J, Behrendt D, Ganz P, Selwyn AP. Manipulating the vascular biology of coronary atherosclerosis in diabetes: new opportunities. J Lab Clin Med. 2001 Feb; 137(2):82-92. PMID: 11174464.
    Citations:    Fields:    Translation:Humans
  146. Kinlay S, Fang JC, Fukumoto M, Hikita H, Creager MA, Selwyn AP, Ganz P. Endothelium-derived nitric oxide actively regulates arterial elasticity in humans in-vivo. 2000.
  147. Kinlay S, Behrendt D, Wainstein MV, Beltrame JF, Fang JC, Creager MA, Selwyn AP, Ganz P. Endothelin-1 enhances constrictor tone in atherosclerotic coronary arteries in humans. 2000.
  148. Fang JC, Kinlay S, Beltrame JF, Behrendt D, Wainstein MV, Frei B, Morrow JD, Suh JH, Mudge GH, Selwyn AP, Ganz P. Vitamin C and E retard the progression of transplant associated arteriosclerosis: A prospective double-blinded randomized trial. 2000.
  149. Kinlay S, Fang JC, Fukumoto M, Delagrange D, Frei B, Morrow JD, Suh JH, Ganz P, Creager MA, Selwyn AP. Long-term effect of vitamins C and E on brachial artery endothelial function: A controlled trial in patients with coronary disease. 2000.
  150. Stone PH, Coskun AU, Kinlay S, Wang J, Sonka M, Segun I, Feldman CL. Quantification of areas of low endothelial shear stress in human coronary arteries in vivo to predict progression of atherosclerosis and formation of vulnerable plaque. 2000.
  151. Kinlay S, Fang JC, Behrendt D, Wainstein MV, Frei B, Morrow JD, Suh JH, Ganz P, Selwyn AP. Long-term effect of vitamins E and C on coronary endothelial function: A randomized controlled trial in patients with atherosclerosis. 2000.
  152. Kinlay S, Selwyn AP, Ganz P, O'Gara PT. Lack of compensatory enlargement at sites of coronary vasospasm: identification by ultrasound and successful treatment with stenting. Clin Cardiol. 2000 Nov; 23(11):865-8. PMID: 11097137.
    Citations: 1     Fields:    Translation:Humans
  153. Kinlay S, Ganz P. Relation between endothelial dysfunction and the acute coronary syndrome: implications for therapy. Am J Cardiol. 2000 Oct 19; 86(8B):10J-13J; discussion 13J-14J. PMID: 11081444.
    Citations: 9     Fields:    Translation:Humans
  154. Fang JC, Kinlay S, Wexberg P, Amirzadeh A, Gibson CM, Selwyn AP, Ganz P. Use of the thrombolysis in myocardial infarction frame count for the quantitative assessment of transplant-associated arteriosclerosis. Am J Cardiol. 2000 Oct 15; 86(8):890-2. PMID: 11024410.
    Citations: 2     Fields:    Translation:Humans
  155. Popma JJ, Sawyer M, Selwyn AP, Kinlay S. Lipid-lowering therapy after coronary revascularization. Am J Cardiol. 2000 Aug 24; 86(4B):18H-28H. PMID: 11021252.
    Citations: 2     Fields:    Translation:Humans
  156. Fang JC, Kinlay S, Hikita H, Suh JH, Piana RN, Selwyn AP, Frei B, Morrow JD, Ganz P. Relation of preservation of nitric oxide-dependent coronary vasomotor function to plasma vitamin C concentrations in cardiac transplant recipients. Am J Cardiol. 2000 Aug 15; 86(4):460-2. PMID: 10946045.
    Citations:    Fields:    Translation:Humans
  157. Prpic R, Popma JJ, Kinlay S, Adams M, Kwok OH. Outcome after intracoronary pullback atherectomy: quantitative angiographic results from a multicenter registry. 2000.
  158. Adams MR, Blake GJ, Kinlay S, Selwyn AP, Popma JJ. Angioseal use in high risk coronary interventions: is it safe?. 2000.
  159. Page J, Heller RF, Kinlay S, Lim LL, Qian W, Suping Z, Kongpatanakul S, Akhtar M, Khedr S, Macharia W. Where do developing World clinicians obtain evidence for practice: a case study on pneumonia. J Clin Epidemiol. 2000 Jul; 53(7):669-75. PMID: 10941942.
    Citations: 5     Fields:    Translation:Humans
  160. Orford JL, Kinlay S, Ganz P, Selwyn AP. Treating ambulatory ischemia in coronary disease by manipulating the cell biology of atherosclerosis. Curr Atheroscler Rep. 2000 Jul; 2(4):321-6. PMID: 11122761.
    Citations: 1     Fields:    Translation:Humans
  161. Libby P, Aikawa M, Kinlay S, Selwyn A, Ganz P. Lipid lowering improves endothelial functions. Int J Cardiol. 2000 Jun 30; 74 Suppl 1:S3-S10. PMID: 10856767.
    Citations: 4     Fields:    Translation:HumansAnimals
  162. Adams MR, Kinlay S, Blake GJ, Orford JL, Ganz P, Selwyn AP. Pathophysiology of atherosclerosis: development, regression, restenosis. Curr Atheroscler Rep. 2000 May; 2(3):251-8. PMID: 11122751.
    Citations: 1     Fields:    Translation:Humans
  163. Kinlay S, Grewal J, Manuelian D, Fang J, Selwyn AP, Bittl JA, Ganz P. High coronary blood flow velocity and Reynolds number predict clinical outcome after coronary angioplasty. 2000.
  164. Kinlay S, Burgess B, Rizzo R, Cordella N, Cabral V, O’Donnell C, Plutzky J. Conventional coronary risk factors are more frequent in coronary artery bypass recipients with premature atherosclerosis. 2000.
  165. Beckman JA, Ganz J, Creager MA, Ganz P, Kinlay S. Coronary artery calcification extent is directly related to clinical stability in patients with coronary artery disease. 2000.
  166. Beckman J, Kinlay S, Kirshenbaum J. Two instructive cases from the Brigham archives. Second US-Japanese dialogue on lipid disorders and coronary artery disease. Plutzky J, Libby P, Nakamura H, eds. 2000; 69-77.
  167. Adams MR, Kinlay S, Blake GJ, Orford JL, Ganz P, Selwyn AP. Atherogenic lipids and endothelial dysfunction: mechanisms in the genesis of ischemic syndromes. Annu Rev Med. 2000; 51:149-67. PMID: 10774458.
    Citations: 6     Fields:    Translation:Humans
  168. Beltrame JF, Wainstein MV, Kinlay S, Delagrange DM, Selwyn AP, Ganz P. The role of endothelin-1 and endothelin-A receptors in the control of coronary tone in humans. 1999.
  169. Kinlay S, Plutzky J. Effect of lipid-lowering therapy on vasomotion and endothelial function. Curr Cardiol Rep. 1999 Sep; 1(3):238-43. PMID: 10980848.
    Citations: 5     Fields:    Translation:Humans
  170. Kinlay S, Fang JC, Hikita H, Ho I, Delagrange DM, Frei B, Suh JH, Gerhard M, Creager MA, Selwyn AP, Ganz P. Plasma alpha-tocopherol and coronary endothelium-dependent vasodilator function. Circulation. 1999 Jul 20; 100(3):219-21. PMID: 10411842.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  171. Fang JC, Kinlay S, Hikita H, Witztum JL, Selwyn AP, Ganz P. An IgG auto-antibody to oxidized LDL is related to impaired coronary endothelial function in patients after cardiac transplantation. 1999.
  172. Piana RN, Ahmed WH, Chaitman B, Ganz P, Kinlay S, Strony J, Adelman B, Bittl JA. Effect of transient abrupt vessel closure during otherwise successful angioplasty for unstable angina on clinical outcome at six months. Hirulog Angioplasty Study Investigators. J Am Coll Cardiol. 1999 Jan; 33(1):73-8. PMID: 9935011.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  173. Kinlay S, Selwyn AP, Ganz P. Endothelium as a target of the risk factors in cardiovascular disease. Endothelium, nitric oxide, and atherosclerosis. Panza JA, Cannon RO III, eds. 1999; Chapter 17:227-241.
  174. Fang JC, Kinlay S, Kundsin R, Ganz P. Chlamydia pneumoniae infection is frequent but not associated with coronary arteriosclerosis in cardiac transplant recipients. Am J Cardiol. 1998 Dec 15; 82(12):1479-83. PMID: 9874051.
    Citations: 2     Fields:    Translation:HumansCells
  175. Kinlay S, Hikita H, Fang JC, Haley EA, Delagrange D, Roddy M-A, Woodcome MB, Creager MA, Ganz P. Endothelium-dependent nitric oxide augments arterial distensibility in the brachial artery of humans. 1998.
  176. Fang JC, Kinlay S, Hikita H, Suh JP, Piana RN, Selwyn AP, Frei B, Ganz P. Endogenous antioxidant vitamin C is associated with preserved coronary endothelial function in cardiac transplant recipients. 1998.
  177. Fang JC, Kinlay S, Wexberg P, Amirzadeh A, Ganz P. TIMI Frame Count for quantitative assessment of transplant-associated arteriosclerosis. 1998.
  178. Kinlay S, Fang JC, Hikita H, Delagrange D, Frei B, Suh JP, Gerhard M, Creager MA, Ganz P, Selwyn AP. Endogenous plasma vitamin E is associated with preserved endothelial function in the coronary arteries of patients with atherosclerosis. 1998.
  179. Kinlay JR, O'Connell DL, Kinlay S. Incidence of mastitis in breastfeeding women during the six months after delivery: a prospective cohort study. Med J Aust. 1998 Sep 21; 169(6):310-2. PMID: 9785526.
    Citations: 24     Fields:    Translation:Humans
  180. Kinlay S, Gerhard M, Selwyn AP, Creager MA, Ganz P. Estrogen’s effects on human coronary and peripheral vasoreactivity. . Estrogen and the vessel wall. Rubanyi GM, Kauffman R, eds. 1998; 251-260.
  181. Kinlay S, Selwyn AP, Ganz P. The potential role of the endothelium in acute coronary syndromes: Vasomotion, inflammation, thrombosis. The vulnerable atherosclerotic plaque: Understanding, identification, and modification. Fuster V, ed. 1998; Chapter 21:345-357.
  182. Kinlay S, Ganz P. The endothelium as a target organ for cardiovascular risk factors. Cardiovascular Risk Factors (http://crf.medynet.com). 1998; 8:3-11.
  183. Kinlay S, Selwyn AP, Libby P, Ganz P. Inflammation, the endothelium, and the acute coronary syndromes. J Cardiovasc Pharmacol. 1998; 32 Suppl 3:S62-6. PMID: 9883750.
    Citations: 11     Fields:    Translation:Humans
  184. Piana RN, Kinlay S. Advanced coronary imaging . Atlas of cardiac imaging. Braunwald EB, Lee RT, eds. 1998; 6.1-6.25.
  185. Hardie KL, Kinlay S, Hardy DB, Wlodarczyk J, Silberberg JS, Fletcher PJ. Reproducibility of brachial ultrasonography and flow-mediated dilatation (FMD) for assessing endothelial function. Aust N Z J Med. 1997 Dec; 27(6):649-52. PMID: 9483230.
    Citations: 8     Fields:    Translation:Humans
  186. Kinlay S, Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol. 1997 Nov 06; 80(9A):11I-16I. PMID: 9375937.
    Citations: 40     Fields:    Translation:Humans
  187. Selwyn AP, Kinlay S, Ganz P. Atherogenesis and ischemic heart disease. Am J Cardiol. 1997 Oct 30; 80(8B):3H-7H. PMID: 9372991.
    Citations: 2     Fields:    Translation:HumansCells
  188. Lim LL, Kinlay S, Fisher JD, Dobson AJ, Heller RF. Can ECG changes predict the long-term outcome in patients admitted to hospital for suspected acute myocardial infarction? Cardiology. 1997 Sep-Oct; 88(5):460-7. PMID: 9286509.
    Citations: 2     Fields:    Translation:Humans
  189. Leong DC, Kinlay S, Ackland S, Bonaventura A, Stewart JF. Low-risk febrile neutropenia in a medical oncology unit. Aust N Z J Med. 1997 Aug; 27(4):403-7. PMID: 9448881.
    Citations:    Fields:    Translation:Humans
  190. Kinlay S, Elliott H, Heller RF. Identifying individuals with high fat levels and low P:S ratios, in their diets, for intensive dietary intervention. J Intern Med. 1997 May; 241(5):407-14. PMID: 9183309.
    Citations:    Fields:    Translation:Humans
  191. Selwyn AP, Kinlay S, Creager M, Libby P, Ganz P. Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease. Am J Cardiol. 1997 Mar 06; 79(5A):17-23. PMID: 9127617.
    Citations: 10     Fields:    Translation:HumansAnimals
  192. Selwyn AP, Kinlay S, Libby P, Ganz P. Atherogenic lipids, vascular dysfunction, and clinical signs of ischemic heart disease. Circulation. 1997 Jan 07; 95(1):5-7. PMID: 8994406.
    Citations: 17     Fields:    Translation:Humans
  193. Invited Reviewer for: Goa KL, Barradell LB, McTavish D. Simvastatin: A reappraisal of its cost effectiveness in dyslipidaemia and coronary artery disease. PharmacoEconomics. 1997; 11:89-110.
  194. Neil A, Leitch JW, Kinlay S. Cost-effective assessment of cardiac arrhythmias. Cost-effective diagnosis and treatment of coronary artery disease. Topics in Clinical Cardiology. Talley JD, Mauldin P, Becker M, eds. 1997; 178-188.
  195. Kinlay S, Selwyn AP, Delagrange D, Creager MA, Libby P, Ganz P. Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points. Curr Opin Lipidol. 1996 Dec; 7(6):389-97. PMID: 9117144.
    Citations: 7     Fields:    Translation:HumansAnimals
  196. Kinlay S, Dobson AJ, Heller RF, McElduff P, Alexander H, Dickeson J. Risk of primary and recurrent acute myocardial infarction from lipoprotein(a) in men and women. J Am Coll Cardiol. 1996 Oct; 28(4):870-5. PMID: 8837562.
    Citations:    Fields:    Translation:Humans
  197. Kinlay S, Wall RC, Page JH, Fenning S, Bastian BC. Effect of wetting the mouth on aortic blood pressure just before taking sublingual nitrates. Am J Cardiol. 1996 Sep 01; 78(5):555-8. PMID: 8806342.
    Citations:    Fields:    Translation:HumansCellsCTClinical Trials
  198. Kinlay S. Cost-effectiveness of coronary angioplasty versus medical treatment: the impact of cost-shifting. Aust N Z J Med. 1996 Feb; 26(1):20-6. PMID: 8775524.
    Citations: 2     Fields:    Translation:Humans
  199. Kinlay S, Leitch JW. Efficacy of Holter Monitors [Letter]. Ann Intern Med. 1996; 125:697-698.
  200. Kinlay S, Leitch JW, Neil A, Chapman BL, Hardy DB, Fletcher PJ. Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations. A controlled clinical trial. Ann Intern Med. 1996 Jan 01; 124(1 Pt 1):16-20. PMID: 7503472.
    Citations: 35     Fields:    Translation:HumansCTClinical Trials
  201. Hardie K, Kinlay S, Hardy DB, Wlodarczyk J, Silberberg JS, Fletcher PJ. Reproducibility of flow-mediated dilatation evaluated by brachial artery ultrasound in normal subjects. 1996.
  202. Fenning SD, Wall R, Kinlay S, Bastian BC. Randomised controlled trial to assess water in improving the action of sublingual nitrates. 1995.
  203. Kinlay S, D'Este K, Malcolm J. A new method of ECG coding for acute myocardial infarction. 1995.
  204. Kinlay S, Leitch J, Hardy D, Chapman B, Fletcher P. Diagnostic yield and cost-effectiveness of transtelephonic compared to holter monitoring in patients with palpitations. 1995.
  205. Kinlay S, Dobson A, Heller RF, McElduff P. The risk of primary and recurrent acute myocardial infarction from Lipoprotein(a). 1995.
  206. Malcolm J, Kinlay S, D’Este C. ECG Diagnosis: A self-instruction manual for coders. Hunter Region Heart Disease Prevention Program. 1995.
  207. Kinlay S. Cost-effectiveness of PTCA versus Medical treatment in an Australian Public Teaching Hospital. 1995.
  208. Kinlay S, D'Este K, Malcolm J. A new method of ECG coding for acute myocardial infarction. 1995.
  209. Kinlay S, Buckley NA. Magnesium sulfate in the treatment of ventricular arrhythmias due to digoxin toxicity. J Toxicol Clin Toxicol. 1995; 33(1):55-9. PMID: 7837314.
    Citations: 6     Fields:    Translation:Humans
  210. Kinlay S, Leitch J, Hardy D, Kemp R, Chapman B, Fletcher P. Improved yield of transtelephonic compared to holter monitoring in cardiac arrhythmias. 1994.
  211. Kinlay S, O'Connell D, Evans D, Halliday J. The cost-effectiveness of different blood-cholesterol-lowering strategies in the prevention of coronary heart disease. Aust J Public Health. 1994 Mar; 18(1):105-10. PMID: 8068781.
    Citations: 1     Fields:    Translation:Humans
  212. Kinlay S, O'Connell D, Evans D, Halliday J. A new method of estimating cost effectiveness of cholesterol reduction therapy for prevention of heart disease. Pharmacoeconomics. 1994 Mar; 5(3):238-48. PMID: 10146898.
    Citations: 2     Fields:    Translation:Humans
  213. Kinlay S, Bellamy G, Hardy D, Bastian B, Fletcher P. Predictors of final stenosis after PTCA. 1994.
  214. Kinlay S, O'Connell D, Evans D. The cost-effectiveness of different strategies to reduce coronary heart disease. 1993.
  215. Gleeson M, Kinlay S. Choice of anticoagulant affects measurement of plasma fibrinogen. Clin Chem. 1993 Aug; 39(8):1754-5. PMID: 8353977.
    Citations:    Fields:    Translation:Humans
  216. Kinlay S, Gleeson M, Dobson AJ, Heller RF. Effect of processing time and storage on fibrinogen content of EDTA plasma assayed by radial immunodiffusion. Clin Chem. 1992 Jun; 38(6):1197. PMID: 1597001.
    Citations:    Fields:    Translation:Humans
  217. Kinlay S, O'Connell D, Evans D, Francis L. The validity of estimating heart disease reduction from a Framingham logistic equation. J Clin Epidemiol. 1992 May; 45(5):553-60. PMID: 1588361.
    Citations: 2     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  218. Kinlay S. How to measure risk--relative and attributable. Med J Aust. 1992 Apr 06; 156(7):469-71. PMID: 1556974.
    Citations:    Fields:    Translation:Humans
  219. Kinlay S. How to measure risk--relative and attributable. (for the series "Principles behind Practice"). Med J Aust. 1992; 156:469-471.
  220. Kinlay S, Heller RF, Halliday JA. A simple score and questionnaire to measure group changes in dietary fat intake. Prev Med. 1991 May; 20(3):378-88. PMID: 1862059.
    Citations: 3     Fields:    Translation:Humans
  221. Kinlay S, Dobson AJ, Heller RF, Dickeson JE, Ryan S. Lipid and apolipoprotein levels in an Australian community. Med J Aust. 1991 Feb 04; 154(3):170-5. PMID: 1988787.
    Citations: 1     Fields:    Translation:Humans
  222. Kinlay S, Olson LG. Patterns of use of chest physiotherapy in a teaching hospital. Aust Clin Rev. 1991; 11(4):154-8. PMID: 1804076.
    Citations:    Fields:    Translation:Humans
  223. Kinlay S, Heller RF. Randomised controlled trial of adults knowing their cholesterol level on the average change in blood cholesterol. 1990.
  224. Kinlay S, Heller RF. Effectiveness and hazards of case finding for a high cholesterol concentration. BMJ. 1990 Jun 16; 300(6739):1545-7. PMID: 2372619; PMCID: PMC1663079.
    Citations: 12     Fields:    Translation:Humans
  225. Gleeson M, Kinlay S, Dobson AJ, Heller RF, Burns CJ. Effect of storage on plasma fibrinogen concentrations. 1990.
  226. Alexander HM, Beal CP, Clarke RM, Dobson AJD, Heller RF, Kinlay S, Lloyd DM, Russell MA, Ryan S, Shaw CD. Hunter Region Heart Disease Prevention Programme; Risk Factor Prevalence Study 1988-89 Data Book. 1990.
  227. Kinlay S, Heller RF. Selective screening for high cholesterol in Australian general practice: the Newcastle Cholesterol Prediction Study. J Gen Intern Med. 1990 Jan-Feb; 5(1):1-8. PMID: 2299425.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  228. Kinlay S. Blood cholesterol screening: The effects on diet and average blood cholesterol and the development of a more selective approach. [PhD dissertation]. 1989.
  229. Kinlay S. Comparison of Reflotron and laboratory cholesterol measurements. Med J Aust. 1988 Aug 01; 149(3):126-9. PMID: 3398799.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  230. Kinlay S. High cholesterol levels: is mass screening the best option? Med J Aust. 1988 Jun 20; 148(12):635-7. PMID: 3132589.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  231. Kinlay S. Preventive medicine in undergraduate medical education. Med J Aust. 1987 Apr 20; 146(8):425-7, 430. PMID: 3614055.
    Citations:    Fields:    Translation:Humans
  232. Heller RF, Sanson?Fisher R, Kinlay S, eds. Preventive medicine in undergraduate medical education. Report of a workshop sponsored by the Better Health Commission and organised by the University of Newcastle. 1986.
  233. Yu VY, Kinlay S, Orgill AA, Bajuk B, Astbury J. Outcome of very low birthweight infants who required prolonged hospitalization. Aust Paediatr J. 1984 Nov; 20(4):293-6. PMID: 6084995.
    Citations:    Fields:    Translation:Humans
  234. Kinlay S, Yu VYH, Orgill AA, Bajuk B, Astbury J. Prolonged initial hospitalisation in very low birth weight infants. 1984.
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Kinlay's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (526)
Explore
_
Co-Authors (49)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.